Experimental Ebola Vaccine Administered to Hundreds in Guinea as Outbreak Spreads to Liberia
April 8th 2016Recent Ebola-linked deaths in Guinea caused the World Health Organization (WHO) Guinea office to implement a “ring vaccination” strategy in which it administered an experimental Ebola vaccine on 800 of 1000 suspected cases, including 182 suspected at high-risk.
Long-Term Antibiotics No Benefit for Chronic Lyme Disease Symptoms
April 6th 2016The results of a double-blind, randomized, placebo-controlled trial in patients with persistent symptoms of Lyme disease have shown that long-term antibiotic treatment does not lead to better outcomes than short-term antibiotic treatment does.
Parasitic Diseases of the Central Nervous System: The Diagnostic Challenge
April 6th 2016This article is the second in a 3-part series on parasitic diseases of the central nervous system (CNS) and highlights some of the techniques that clinicians use for the diagnosis of parasitic diseases of the CNS.
Insecticide-Treated Nets Prove to be Effective Malaria Control
April 5th 2016The findings of a new study reinforce the value of making insecticide-treated nets and indoor residual spraying of insecticides universally available—even in countries where the mosquitoes that transmit disease bite primarily outdoors.
Utilizing Whole Genome Sequencing to Combat MRSA Infections
April 4th 2016Researchers at Jiangsu University in China have demonstrated that whole genome sequencing can be used to confirm findings from traditional bacterial genotyping methods to identify outbreaks of MRSA and control nosocomial transmission.
Knowledge of Cholera Lacking in Regions Where the Disease is Most Prevalent
April 1st 2016The findings of a recent study suggest that knowledge of cholera and its symptoms is sorely lacking among female caretakers in the Indian sub-continent—despite the fact that the disease has been present in the region for centuries.
hMPV: Is This Relatively New Paramyxovirus Cause for Concern?
March 28th 2016Human metapneumovirus (hMPV), of the paramyxovirus family, was discovered in 2001. hMPV can affect people of all ages, however, older adults, children and individuals with weak immune systems are at highest risk of contracting the virus.